Literature DB >> 7654266

Expression in mammalian cells, purification and characterization of recombinant human pancreatic ribonuclease.

N Russo1, M de Nigris, A Ciardiello, A Di Donato, G D'Alessio.   

Abstract

A synthetic cDNA coding for human pancreatic RNase, equipped with a secretion signal sequence, was cloned and stably expressed in Chinese hamster ovary cells. The recombinant RNase, secreted into the culture medium, was purified and characterized. It was found to be indistinguishable, by structural and catalytic parameters, from the enzyme isolated from human pancreas. Furthermore, the glycosylated forms were separated from the non-glycosylated form. Up until now, human RNases have been isolated only in small amounts from autopic specimens. This has hindered the exploitation of a human RNase for the construction of immunotolerated immunotoxins. On the other hand, the availability of an effective system for the expression of a human RNase may render feasible the transfer, by protein engineering, of the interesting pharmacological actions of non-human RNase [1993 Trends Cell Biol. 3, 106-109] to an immunotolerated, human RNase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7654266     DOI: 10.1016/0014-5793(93)80660-m

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  A dimeric mutant of human pancreatic ribonuclease with selective cytotoxicity toward malignant cells.

Authors:  R Piccoli; S Di Gaetano; C De Lorenzo; M Grauso; C Monaco; D Spalletti-Cernia; P Laccetti; J Cinátl; J Matousek; G D'Alessio
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

2.  Consequences of the Endogenous N-Glycosylation of Human Ribonuclease 1.

Authors:  Valerie T Ressler; Ronald T Raines
Journal:  Biochemistry       Date:  2019-01-29       Impact factor: 3.162

3.  1H and 15N sequential assignment and solution secondary structure of 15N labelled human pancreatic ribonuclease.

Authors:  A el-Joubary; M Bruix; J Santoro; V Cafaro; R Scognamiglio; A Di Donato; G D'Alessio; K E Kövér; G Batta; L Szilágyi; M Rico
Journal:  J Biomol NMR       Date:  1999-11       Impact factor: 2.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.